Bayer vs Sanofi (BAYN.DE vs SAN.PA)
Bayer (BAYN.DE) vs Sanofi (SAN.PA) in plain English: P/E, growth, margins, debt and dividend side by side, key differences and which fits each investor profile.
Bayer (BAYN.DE) and Sanofi (SAN.PA) compete in healthcare and pharma. Here are Bayer and Sanofi side by side with their real figures as of November 4, 2026: what sets them apart, which fits each kind of investor and the most common questions, without telling you whether to buy Bayer or Sanofi.
Bayer vs Sanofi: the figures
| Figure | Bayer | Sanofi |
|---|---|---|
| Share price | €54.24 (November 4, 2026) | €84.10 (November 4, 2026) |
| Market cap | €53.3 billion | €100.8 billion |
| P/E (TTM) | N/A | 24.3x |
| Forward P/E | 11.2x | 9.0x |
| Revenue growth (quarter) | +1.2% | +15.7% |
| Net margin (TTM) | -3.8% | 8.2% |
| Net debt / EBITDA | 3.3x | 1.0x |
| Dividend yield | 0.22% | 5.09% |
| Beta | 0.81 | 0.27 |
Bayer and Sanofi figures from Yahoo Finance, the same source the Fintols analysis uses, retrieved on November 4, 2026; N/A means that Bayer or Sanofi figure is not available, and we never estimate it.
3 key differences between Bayer and Sanofi
- Dividend: Sanofi yields 5.09% at today's price and Bayer yields 0.22%.
- Profitability: for every 100 of sales, Sanofi keeps 8.2 as net profit and Bayer keeps -3.8.
- Growth: Sanofi grew sales +15.7% year on year in its latest quarter, against +1.2% for Bayer.
Bayer or Sanofi: which fits your profile
- If you want growth: Sanofi is growing faster today, so it fits better with investors who put business growth first, usually accepting a higher P/E and a bumpier ride.
- If you want income (dividends): Sanofi pays the higher dividend relative to its price.
- If you prefer caution: Sanofi has less debt relative to its profit, which usually gives more room in a bad year.
Neither Bayer nor Sanofi wins on everything, and owning both is also an option: spreading money across several companies or an index fund reduces what rides on each one.
How Bayer and Sanofi make money
Bayer (BAYN.DE)
Bayer reports three divisions: Crop Science, its largest, selling seeds (Dekalb) and crop protection to farmers; Pharmaceuticals, with prescription drugs such as Xarelto, Eylea and Nubeqa; and Consumer Health, with over-the-counter brands like Aspirin, Bepanthen and Claritin. It sells worldwide, with North America and Europe as its main markets. Full Bayer analysis.
Sanofi (SAN.PA)
Sanofi is a drugmaker focused on its Biopharma business: specialty medicines for immunology, rare diseases and neurology, led by Dupixent, its top-selling product, plus flu, pediatric and booster vaccines. It sells to hospitals, pharmacies and health systems, with the US and Europe as its main markets. Full Sanofi analysis.
Frequently asked questions: Bayer vs Sanofi
Is Bayer or Sanofi the better stock?
Choosing between Bayer and Sanofi depends on what you are looking for. Sanofi is growing faster right now. Fintols does not tell you whether to buy Bayer or Sanofi: it shows you the differences so you can decide.
Which pays a higher dividend, Bayer or Sanofi?
As of November 4, 2026, Sanofi yields 5.09% and Bayer yields 0.22%. Also check how much of their profit Bayer and Sanofi pay out: if it is more than they earn, it cannot last.
Can I own both Bayer and Sanofi?
Yes. Many people spread their money across several companies, such as Bayer and Sanofi, or use index funds so they do not depend on just one. If you are starting out, decide how much you want to invest and for how long before buying Bayer or Sanofi.
More comparisons with Bayer or Sanofi
More companies like Bayer and Sanofi: healthcare and pharma stocks. Educational content about Bayer and Sanofi, not investment advice.